FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to paediatrics. If ionised blood serum calcium is less than 0.9 mmole/l and the relation of ionised Ca/inorganic phosphorus is 0.3 or more, calcium gluconate 1.0 ml is introduced intramuscularly 7-10 times/day in a combination with the oral administration of 10% calcium chloride 5.0 ml 7-10 times/day and 0.5% alcohol solution of vitamin D2 8000 IU a day. If observing comorbid hypomagnesaemia (Mg below 0.66 mmole/l), 25% magnesium sulphate 1 ml is introduced intramuscularly once a day. If the calcium level is less than 0.9 mmole/l and the relation of ionised Ca/inorganic phosphorus is less than 0.3 instead of vitamin D20, Parathyreoidin 25-0.5 ml is administered intramuscularly 3 times a day. If ionised calcium is more than 1.1 mmole/l and magnesium is more than 0.66 mmole/l, 10% calcium chloride 5.0 ml is orally administered 7-10 times a day, and vitamin D2 8000 IU a day or substituting Parathyreoidin in a dose of 0.25-0.5 ml 3 times a day intramuscularly. After the calcium and magnesium levels are stably normalised, Parathyreoidin is replaced by 0.5% alcohol solution of vitamin D2.
EFFECT: using the method enables eliminating hypocalcemia considerably faster, recovering normal blood 25(OH)D that prevents recurrent convulsions.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING RACHITISM IN INFANTS SUFFERING THYROID INSUFFICIENCY | 2014 |
|
RU2560847C2 |
METHOD OF INTEGRATED TREATMENT OF PRIMARY CHRONIC RECURRENT OSTEOMYELITIS IN CHILDREN WITH BACKGROUND SOMATIC STATUS | 2018 |
|
RU2699742C1 |
METHOD FOR CORRECTION OF POSTOPERATIVE HYPOPARATHYROIDISM | 2015 |
|
RU2581023C1 |
METHOD FOR PREDICTION OF HYPOCALCEMIA AFTER PARATHYROIDECTOMY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM | 2022 |
|
RU2822014C2 |
COMPOSITION FOR THE TREATMENT OF BIOTIN-DEFICIENT CONDITIONS IN CHILDREN, AS WELL AS A METHOD OF TREATMENT USING SUCH A COMPOSITION | 2023 |
|
RU2795624C1 |
METHOD OF TREATING PATIENTS WITH ATROPHY OF ALVEOLAR PART OR DENTAL PROCESS IN OSTEOPENIC SYNDROME | 2008 |
|
RU2377012C1 |
METHOD OF TREATING OSTEOPENIC SYNDROME IN POSTMENOPAUSAL OBESITY WOMEN | 2017 |
|
RU2698269C2 |
METHOD FOR PROPHYLAXIS OF CHRONIC FLUORINE OSTEOPATHY IN MODELING FLUORINE INTOXICATION IN EXPERIMENT | 2005 |
|
RU2300374C2 |
AGENT FOR LOW-TURNOVER METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2491940C1 |
METHOD FOR DETERMINING THE RISK OF CALCIINATE DEVELOPMENT IN CASE OF CYSTIC OF KIDNEY DISEASES OF CHILDREN | 2017 |
|
RU2649125C1 |
Authors
Dates
2014-02-27—Published
2012-10-24—Filed